Efeito do estado glicêmico em ratos submetidos ao status epilepticus durante o desenvolvimento by Santiago, Joselita Ferreira Carvalho et al.
Arq Neuropsiquiatr 2006;64(2-A):233-239
Disciplina de Neurologia Experimental, Departamento de Neurologia e Neuro c i ru rgia, Universidade Federal de São Paulo, São Paulo
S P, Brazil (UNIFESP/EPM): 1Aluno de pós-graduação UNIFESP/EPM; 2 PhD, Professor da Disciplina de Imuno-histoquímica e Inflamação,
Faculdade de Medicina da Universidade de São Paulo; 3PhD, Professor Adjunto da Disciplina de Neurologia Experimental UNIFESP/EPM;
4PhD, Professor Titular da Disciplina de Neurologia Experimental UNIFESP/EPM; 5PhD, Professora Livre Docente da Disciplina de
N e u rologia Experimental/Bioquímica, UNIFESP/EPM e Instituto do Coração (INCOR), Faculdade de Medicina, Divisão de Pesquisa,
Universidade de São Paulo (USP). Supported by FAPESP, CNPq, FADA, CAPES.
Received 18 April 2005, received in final form 16 November 2005. Accepted 5 December 2005.
Dra. Joselita F.C. Santiago - Rua Amaturama 1074/38 - 04164-010 São Paulo SP - Brasil. 
EFFECT OF GLYCEMIC STATE IN RATS SUBMITTED
TO STATUS EPILEPTICUS DURING DEVELOPMENT
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ABSTRACT - The effect of glycemic state on status epilepticus (SE) development was studied in animals of
d i ff e rent ages, submitted to pilocarpine model of epilepsy. Groups: I- Rats with 9-day-old (P9): IA. Submitted
to 1SE; IB. Saline-treated; IC. Induced- hyperglycemia; ID. Induced- hyperglycemia+SE; II- Rats submitted to
t h ree consecutive episodes of SE at P7, P8 and P9; III- Rats submitted to 1SE at P17; IV- Rats submitted to
1SE at P21. Hippocampal cell death and the expression of glucose transporter GLUT3 were analyzed in
g roup I. The results demonstrated normoglycemia in the groups IA, IB and II, hypoglycemia in group III
and hyperglycemia in group IV, showing that the glycemia during SE is age dependent . Induced hyper-
glycemia during SE in P9 protected the hippocampal neurons from death and both groups IC and ID pre-
sented increased GLUT3 expression, showing high glucose consumption by the hippocampus.
KEY WORDS: status epilepticus, pilocarpine, glycemia, hippocampus, glucose transporter 3.
Efeito do estado glicêmico em ratos submetidos ao status epilepticus durante o desenvolvi-
mento
RESUMO - O efeito do estado glicêmico sobre o desenvolvimento do status epilepticus (SE) foi estudado
em animais de diferentes idades, submetidos ao modelo de epilepsia por pilocarpina. Grupos: I- Ratos com
nove dias (P9): IA- Submetidos a 1SE; IB- Tratados com salina; IC- Hiperglicemia induzida; ID- Hiperg l i c e m i a
induzida+SE; II- Ratos submetidos a 3 episódios consecutivos de SE em P7, P8 e P9; III- Ratos submetidos a
1SE em P17; IV- Ratos submetidos a 1SE em P21. Foram analisados no grupo I a morte celular hipocampal
e a expressão do transportador de glicose GLUT3. Os resultados mostraram haver normoglicemia nos gru-
pos IA, IB e II, hipoglicemia no grupo III e hiperglicemia no grupo IV, sendo a glicemia durante o SE, idade
dependente. A hiperglicemia induzida durante o SE em P9 protegeu neurônios hipocampais e os gru p o s
IC e ID apresentaram expressão aumentada de GLUT3, mostrando aumento no consumo de glicose pelo
hipocampo. 
PALAVRAS-CHAVE: status epilepticus, pilocarpina, glicemia, hipocampo, transportador de glicose 3. 
Status epilepticus (SE) induced by high doses of p i-
locarpine in rats has received special attention, since
this injury drive on a type of epilepsy in rodents, w h i c h
re p roduce the main clinical and neuro p a t h o l o g i c a l
f e a t u res of human temporal lobe epilepsy. When de-
veloped in adult animals, this experimental model is
able to produce long-lasting SE (acute period, 12h),
a seizure - f ree period (silent period, 14 days) and spon-
taneous re c u rrent seizures (chronic period), which
a re associated to extensive cell loss in several brain
s t ru c t u res and mossy fiber sprouting in the hippocam-
pal form a t i o n1 - 3. The consequences of pilocarpine-in-
duced SE are age dependent. When SE is induced in
7 (P7) to 11 (P11) days-old rats no neuronal damage
or spontaneous re c u rrent seizures has been descri-
b e d4. In addition, when SE is induced between 18
and 24 days, the occurrence of epilepsy-related dam-
age in the brain is less extensive than in adult rats4. 
The occurrence of SE during the perinatal period
or early childhood cause cognitive impairm e n t5 , 6.
H o w e v e r, it remains under controversy whether this
i n j u ry is responsible for epilepsy during the adult-
hood. According to a recent work6 the administra-
tion of LiCl-pilocarpine to P12 and P25 rats was able
to induce impaired memory and ictal activity in adult
animals. In P12 group, the EEG re c o rded 3-4 moths
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after SE showed 75% of animals presenting short
periods (less than 10 sec) of hippocampal sharp waves
that were bilaterally synchronous and did not spre a d
to the cortex. Motor convulsions were never observ e d
in these rats. In addition, all P25 animals exhibited
epileptiform EEG activity and 60% of electrograph-
ic seizures were associated with clonic seizures at sta-
ge 3-5, according to Racine´s scale7.  On the other
hand, several authors have re p o rted high brain glu-
cose consumption during SE. According to Fern a n d e s8,
the hypermetabolism occur in areas associated with
brain damage in older animals. In P10 and P21 rats
the sustained major metabolic activation lead to a
variable extent of damage, which increases with ani-
mal age. Previous data of our group showed the pre s-
ence of hyperglycemia during the first three hours,
after the SE onset, in adult rats. Thus, this hypergly-
cemia could be involved in the brain damage, obser-
ved in these animals after pilocarpine-induced SE. 
Trying to correlate hyperglycemia, neuronal loss
and SE the aim of the present work was to evaluate
the effect of induced-hyperglycemia on neuro n a l
death in P9 rats, submitted to SE as well as the expre s-
sion of brain glucose transporter (GLUT3) in these a n i-
mals. Since older rats show neuronal death in sever a l
brain regions, we also analyzed the blood glucose
levels in animals of different ages, submitted to SE. 
METHOD
The experimental protocol was approved by the Ethical
Committee of Universidade Federal de São Paulo and all
efforts were done to minimize animal suffering.
Male Wistar rats, born and maintained under contro l l e d
condition, using standard light/dark cycle of 12 h, and rat
chow pellets and water ad libitum w e re employed. The
colony room had a temperature of 21±2ºC. The rats were
mate in our laboratories and the day of birth was consider-
ed as day zero (P0). The pups were housed with their moth-
er in appropriate cages until experimentation. For induc-
tion of SE subjects were selected randomly from the appro-
priate cage. At P2 the males were selected and each hatch
was composed by 8 rats, plus the mother.
P ro c e d u res – Male Wistar rat received pilocarpine using
doses ranging from 180 to 380 mg/kg (ip). The diff e re n t
concentrations of pilocarpine necessary to induce SE were
p reviously described by our group, for animals in develop-
m e n t9. P21 rats received 1mg/kg of methyl-scopolamine,
30 min before pilocarpine administration, to reduce periph-
eral effects. Control P21 animals received also methyl-scopo-
lamine and control animals of all ages received an equiva-
lent volume of saline instead pilocarpine. Young animals
(less than P17) did not receive methyl-scopolamine since at
this age this drug can cross the blood-brain barrier, which
is not completely developed, blocking SE induction (our
data not published).
G roup I. Animals submitted to SE at P9 – IA) These rats
w e re submitted to one episode of status epilepticus ( S E )
receiving pilocarpine (380 mg/kg-ip) at P9 (n=6); IB) S i m i l a r
p ro c e d u re was done with control animals (P9), which re-
ceived saline instead pilocarpine (n=6); IC) Hyperglycemia
was induced in P9 animals, through glucose administration,
a c c o rding to protocol described by Reeves1 0. The first dose
(0.2 mL at 50%-ip) was administered 5 min after pilocarpine
injection. The second (0.15 mL at 25%-ip) one hour late
and the third (0.2 mL at 50%-ip) tree hours late; ID) H y p e r-
glycemia associated with SE induction was obtained after
pilocarpine administration in hyperglycemic P9 animals, in-
duced according Reeves10 protocol.
The level of blood glucose was measured at 0, 90, 180
and 360 min. The animals from group I were analyzed by
t h ree diff e rent parameters: blood glucose level, hippocam-
pal cell death (Nissl staining) and hippocampal distribution
of glucose transporter (GLUT3-Immunohistochemistry). In
the rats from groups II, III and IV we only analyzed the blo-
od glucose level. 
Group II. Animals submitted to 3SE at P7, P8 and P9  –
IIA) These rats were submitted to three consecutive episodes
of status epilepticus (3SE) receiving one injection/day of pi-
locarpine (380 mg/kg) at P7, P8 and P9 (n=8); IIB) S i m i l a r
procedure was done with control animals, which received
saline instead pilocarpine (n=8). The level of blood glucose
was measured at 0, 30, 90, 120, 180 and 360 min in all rats. 
G roup III. Animals submitted to 1SE at P17 – I I I A )
Animals (n=8) were submitted to pilocarpine-induced SE
(225 mg/kg); IIIB) Similar pro c e d u re was done with contro l
animals, which received saline instead pilocarpine (n=8)
and the level of blood glucose was measured at 0, 30, 90,
120, 180 and 360 min in all rats.
Group IV. Animals submitted to 1 SE at P21 – IVA) Ani-
mals (n=8) was submitted to pilocarpine-induced SE (180
mg/kg pilocarpine plus 1 mg/kg methyl-scopolamine); IVB)
Similar pro c e d u re was done with control animals, which
received saline instead pilocarpine (n=8) and the level of
blood glucose was measured at 0, 30, 90, 120, 180 and 360
min in all rats.
Blood glucose level – The level of glucose was measu-
red at 0, 30, 90, 120, 180 and 360 min in the blood of al l
animals from all groups using the Advantage monitor
(Roche). For this purpose, one drop of blood was withdrawn
f rom animals’ tail. Rats presenting glucose blood values
equal or superior of 6.16 mmol/L were considered hyper-
glycemic. Those rats presenting glucose level equal or infe-
rior of 3.92 mmol/L were considered hypoglycemic and nor-
moglycemic those animals presenting between 3.92-6.16
mmol/L. 
I m m u n o h i s t o c h e m i s t ry – After 6 h of induced-SE or in
c o n t rol animals the rats were anaesthetized and perf u s e d
t r a n s c a rdially with paraformaldehyde (Labsynth) (15 mL at
1%), followed by paraformaldehyde (40 mL at 4%). The
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brains were removed immediately after perfusion and post-
fixed in paraformaldehyde (4%). Brains were sectioned in
50 µm thicknesses using vibratome, collected, and washed
with PBS (pH 7.4). All sections were treated with 3% H2O2
in PBS to quench endogenous per oxidase and then incu-
bated for 2 h in phosphate saline buffer (PBS) containing
0.1% Triton X-100 (Merck) and milk 5%. After this, the sec-
tions were incubated for 16 h at 4ºC in primary antibody
(mouse anti-GLUT3 1:10 (Santa Cruz) in milk 1%. Following
t h ree washes in PBS, the sections were incubated with the
s e c o n d a ry antibody byotinilated (anti-mouse IgG pero x i-
dase conjugate, 1:200, Sigma) during 2 h. Immunodetection
was perf o rmed using the Vectastain ABC Elite Kit (Ve c t o r
Burlingame, CA, USA) during 90 min and the complex anti-
gen-antibody was visualized using diaminobenzidine (DAB-
Abott). Tissue sections were mounted on glass slides. The
material was studied with a microscope using bright-field
illumination. To study the antibody specificity the primary
antibody was replaced by blocking solution and the immu-
n o h i s t o c h e m i s t ry was perf o rmed as described. The quan-
tification of stained cell was performed in all groups.
Hippocampal cell density – After 6 h of induced SE or
in control animals the rats were anaesthetized and perf u s-
ed transcardially with paraformaldehyde (Labsynth) (15 mL
at 1%) followed by paraformaldehyde (40 mL at 4%). The
brains were removed immediately fixed, dehydrated,
immersed in paraffin, sliced at 12 µm and stained with cre-
syl violet. After Nissl staining the cells present in the hip-
pocampal formation of animals from group I were count-
ed using an image program (Image pro-plus version 4, de-
veloped by Media Cybernetics). Specific regions such as
CA1, CA3, dentate gyrus and hilus were selected and the
cell density was analyzed. Control hippocampi were used
as 100% of cell density in each selected region.
Data analysis – The results  were analyzed using ANO-
VA, followed by Tukey-Kramer pos-test. Values of p<0.05
were considered significant.
RESULTS
Blood glucose level – The blood glucose levels,
followed during 360 min of all animals from gro u p
I. Animals in P9 presented normal level of glucose
blood during 6 h of SE (group IA; IB). Animals fro m
g roup IC and ID presented hyperglycemia from 90 to
360 min after the initial pro c e d u re, showing that the
induction of hyperglycemia was efficient.
The glycemia of animals submitted to three con-
secutives SE at P7, P8, P9 (group II) were not modi-
fied, when compared with saline-treated animals.
Animals submitted to SE at P17 (group III) showed
hypoglycemia at 90, 120, 180 and 360 min, when
c o m p a red with control animals. In contrast, animals
at P21 (group IV) showed a hyperglycemia peak dur-
ing the first 30 min of induced-SE. These results show-
ed that in rats, during early stages of development,
the blood glucose level was not modified by pilo-
carpine-induced SE. Older animals such as those in
P21 already showed a hyperglycemic peak, re s e m-
bling that pattern observed in adult rats. These data
are summarized in Table 1. 
Table 1. Glycemic rates, expressed as mmol/L represent mean ±SD.
Groups Glycemia
0 minutes 30 minutes 90 minutes 120 minutes 180 minutes 360 minutes
Group I IA P9 SE 5.71±14.79 – 4.54±35.92 – 4.59±35.49 4.77±28.92
IB P9 Saline 5.90±16.35 – 5.30±15.99 – 5.24±17.17 4.74±17.57
IC P9 Hyperglycemia 5.61±4.62 – 33.04±13.98*** – 24.30±29.46*** 26.47±25.40***
ID P9 SE+Hyperglycemia 5.65±5.93 – 20.63±25.23*** – 22.72±25.88*** 17.64±32.74***
Group II P7 1ºSE 5.55±14.10 7.18±8.88 7.80±21.47 7.23±20.90 6.76±20.08 5.98±17.17
P7 Saline 5.65±5.60 5.50±13.45 5.45±18.67 5.27±10.22 5.05±6.19 4.87±5.79
P8 2ºSE 5.12±2.28 5.52±14.20 6.29±14.52 5.89±19.80 5.50±28.93 5.26±5.60
P8 Saline 5.81±8.17 5.41±5.80 5.33±12.68 5.10±6.72 4.96±14.20 4.76±5.80
P9 3ºSE 5.82±7.12 5.90±17.37 5.16±19.64 5.95±5.12 5.25±5.83 6.00±12.97
P9 Saline 6.13±8.32 5.69±13.14 5.46±18.92 4.93±15.92 4.71±12.17 4.54±15.20
Group III P17 SE 4.85±10.29 5.33± 2.68 2.48±30.65*** 1.53±7.91*** 1.54±12.41*** 3.01± 22.70*
P17 Saline 5.07± 9.80 4.74±11.70 4.45±15.23 4.49±14.22 4.29±16.40 4.26±18.20
Group IV P21 SE 5.15±6.76 9.69±21.30*** 6.78±18.92 4.22±29.56 4.18±4.16 5.20±20.41
P21 Saline 5.73±9.79 5.13±12.78 5.01±8.62 4.73±16.44 4.46±14.06 4.37±12.00
Groups n=8. ANOVA followed by Tukey-Kramer test (*p<0.05) (***p<0.001).
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GLUT3 immunostaining – The quantitative analy-
sis of GLUT3 immunoreactivity in animals from gro u p
I showed modification in the expression of this glu-
cose transport e r. Slices from saline-treated animals
p resented a weak staining in all hippocampal form a-
tion (Figs 1A, 1B, 2A, 2B and 3). Rats submitted to SE
p resented increased immureactivity against GLUT3,
when compared with control group. This incre a s e d
Fig 1. Photomicrograph of GLUT3 immunostaining in the hippocampal formation. The figures B, D, F and H
show details in 100X  magnifications of  CA3 region.  Saline-treated group (A, B); SE group (C, D); hyper -
glycemia group (E, F); SE+hyperglycemia group (G, H).
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e x p ression was visualized mainly in CA1, CA3, hilus
and dentate gyrus (Figs 1C, 1D, 2C, 2D and 3). Animals
submitted only to hyperglycemia showed moderat-
ed immunoreactivity against GLUT3, which was more
intense when compared with saline-treated animals
and less stained when compared with pilocarpine-
induced SE group (Figs 1E, 1F,2E, 2F and 3). Rats sub-
mitted to SE plus hyperglycemia showed intense ex-
Fig 2. Photomicrograph of GLUT3 immunostaining in the hippocampal formation. The figures B, D, F  and
H show details  in 100X magnification of dentade  gyrus  hilus region. Saline-treated group (A, B); SE gro u p
(C, D); hyperglycemia group (E, F); SE+hyperglycemia group (G, H).
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pression of GLUT3. This staining could be visualized
in all hippocampal formation (Figs 1G, 1H, 2G, 2H
and 3) in similar regions to that found in SE gro u p .
All quantitative results are shown in Figure 3.
Cell density – The cell density analyzed by Nissl
staining in all animals from group I showed that ani-
mals submitted to SE at P9 presented cell death in
CA3 and hilus regions. Animals submitted only to hy-
p e rglycemia also showed cell loss in the hilus re g i o n
of hippocampal formation. Rats submitted to SE plus
h y p e rglycemia showed cell death only in hilus re g i o n ,
showing that the high glucose blood level pro t e c t
neurons from CA3 region (Fig 4).
DISCUSSION
To analyze the impact of a brain injury we should
consider the age of the subject. The same type of
a g g ression can cause diff e rent damage degree in the
Fig 3. Number of cells in the hipocampus. Saline- animals saline-
treated; SE- animals submitted to SE; Hyperglycemia- animals
submitted to hyperglycemia; SE+hyperglycemia-animals sub -
mitted to SE plus hyperglycemia. A) CA1 region; B) CA3 re g i o n ;
C) dentate gyrus hilus region; D) dentate gyrus region. Gro u p s
(n=8) of male Wistar rats 9-day old (P9). The data are expre s s e d
as percentge of Saline group. ANOVA followed by Tu k e y - K r a -
mer test (*p<0,05) (**p<0,01) (***p<0,001).
Fig 4. Number of neurons reimaining of GLUT3 immunostain -
ing in the hippocampal formation. Hyperglycemia-animals sub -
mitted to hyperglycemia, SE-animals submitted to SE Hyper -
glycemia+SE- animals submitted to SE plus hypeglycemia. A)
CA1 region, B) CA3 region, C) dentate gyrus hilus region, D)
dentate gyrus region. Groups (n=8) of male Wistar rats with n i n e
days of life (P9). The data are expressed as percentage of saline
g roup. ANOVA followed by TUKEY-KRAMER test (*p< 0,05)
(**p<0,01) (***p<0,001).
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brain, depending on the stage of maturation of the
n e rvous system. One, between several diff e re n c e s
found in adults and developing animals is the rate
of glucose consumption. The brain of newborn ani-
mals consumes 20% less glucose than adult brain1 1.
In previous study done by our group we found that
adult rats, submitted to long lasting SE showed hyper-
glycemia during the first 3 h of pilocarpine-induced
SE. This hyperglycemia may facilitate the entrance of
glucose in the brain and could be involved in cell
death during SE. 
Since developing animals presented normal blood
glucose level and less cell death after induced-SE a
question appears “could the increased glucose level
in the brain intensify the cell death due to long-last-
ing SE”. In this context, a group of P9 rats was sub-
mitted to SE plus hyperglycemia. Our results showed
that only the hyperglycemia is able to kill neuro n s ,
mainly in hilus region. In contrast, animals pre s e n t-
ing SE plus hyperglycemia presented less cell death
in CA3 region, showing that the increased level of
glucose in the brain can protect neurons from this
specific region. These data are in agreement with
those re p o rted by several authors1 2 , 1 3, who described
a neuro p rotector function of glucose during ischemia,
in developing animals. Other works also re p o rt that
h y p e rglycemia protects cerebral ischemia, incre a s i n g
the survival of animals submitted to hypoxia or anox-
ia14,15.
During SE, occurs hypermetabolism in the brain,
p romoted by intense neuronal activity8. In this con-
text, high amount of glutamate is released, activat-
ing receptors related to sodium and calcium entrance.
The cell edema, associated to increased activity of
p roteases, nucleases and lipases may kill the cell by
e x c i t o t o x i c i t y1 6. With high glucose levels in the brain
the amount of ATP can increase, facilitating all AT P -
dependent brain reaction, which could support the
n e u ro p rotection found in animals, submitted to SE
plus hyperglycemia. However, a conflicting data is
also re p o rted in this work, which is related to cell
death, found in the hippocampus of animals only
submitted to hyperglycemia. More study should be
done to understand this phenomenon.
P17 animals showed hypoglycemia, during the
first hours of SE. Pro b a b l y, in these animals the brain
glucose consumption is gre a t e r, resulting in a plas-
matic reduction in this carbohydrate. Older animals
(P21) already presented hyperglycemia during the
first hours of SE, resembling the data found in adult
animals. However, we do not know if the hypergly-
cemia occurs due to a direct action of the pilocarpine
on pancreatic cells, modifying insulin release and/or
if the SE acting over the hypothalamic nucleus would
be able to modify this hormone secretion.
C o n c e rning to the expression of GLUT3 by ani-
mals from group I we found increased levels of this
glucose transporter in animals presenting SE, hyper-
glycemia and in those presenting SE plus hyperg l y-
cemia. These data showed increased metabolic rate
and high glucose consumption in condition of SE and
hyperglycemia, which is exacerbated when the SE is
associated with hyperglycemia. These data are in
a c c o rdance with previous re p o rt s1 7 - 1 9 and show impor-
tant finding concerning to the function of glucose
metabolism during SE, in animals during develop-
ment. 
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